A B C D Pbmcs Were Either Incubated With 1000 Uml Interferon Or

(A, B, C, D) PBMCs were either incubated with 1000 U/ml interferon-β or ...
(A, B, C, D) PBMCs were either incubated with 1000 U/ml interferon-β or ...
IL-1 concentrations. PBMCs were incubated with either medium or 1 μg/ml ...
IL-1 concentrations. PBMCs were incubated with either medium or 1 μg/ml ...
(A) PBMCs from healthy donors were incubated with 1000 U/ml ...
(A) PBMCs from healthy donors were incubated with 1000 U/ml ...
PBMCs from healthy donors were incubated with 1000 U/ml interferon-β ...
PBMCs from healthy donors were incubated with 1000 U/ml interferon-β ...
(a) PBMCs were incubated for 24 hrs with or without the isu peptide ...
(a) PBMCs were incubated for 24 hrs with or without the isu peptide ...
A. Resting PBMCs were incubated with anti-TIM3-APC or isotype control ...
A. Resting PBMCs were incubated with anti-TIM3-APC or isotype control ...
Human PBMCs were incubated with β-glu6 (100 μg/mL) (lower panels) or ...
Human PBMCs were incubated with β-glu6 (100 μg/mL) (lower panels) or ...
a PBMCs from CLL patients (n = 16) were incubated for 24 h with medium ...
a PBMCs from CLL patients (n = 16) were incubated for 24 h with medium ...
(A) 2x106 human PBMCs or purified CD4+ T cells were incubated with ...
(A) 2x106 human PBMCs or purified CD4+ T cells were incubated with ...
PBMC were incubated with cytokines (1–1000 pg/ml) either derived from ...
PBMC were incubated with cytokines (1–1000 pg/ml) either derived from ...
PBMC (2.5x1O6/ml) were incubated a t 37°C in a 5% C 0 2 atmosphere for ...
PBMC (2.5x1O6/ml) were incubated a t 37°C in a 5% C 0 2 atmosphere for ...
(A) One million PBMCs were first incubated with α-GalCer-CD1d-Tet-PE ...
(A) One million PBMCs were first incubated with α-GalCer-CD1d-Tet-PE ...
PBMCs were labeled with CFSE and incubated for 6 days in the presence ...
PBMCs were labeled with CFSE and incubated for 6 days in the presence ...
A–D) Neutrophils ( , ) and PBMC (•, ) were incubated with ( , •) or ...
A–D) Neutrophils ( , ) and PBMC (•, ) were incubated with ( , •) or ...
A - Human peripheral blood mononuclear cells (PBMC) were incubated with ...
A - Human peripheral blood mononuclear cells (PBMC) were incubated with ...
PBMC were incubated for one hour with 0, 3, 10 or 30 µg/ml HNP-1 (A ...
PBMC were incubated for one hour with 0, 3, 10 or 30 µg/ml HNP-1 (A ...
PBMC (2.5x1O6/ml) were incubated a t 37°C in a 5% C 0 2 atmosphere for ...
PBMC (2.5x1O6/ml) were incubated a t 37°C in a 5% C 0 2 atmosphere for ...
a – PBMC were incubated in 96 well with increasing concentrations of ...
a – PBMC were incubated in 96 well with increasing concentrations of ...
(A) PBMCs were incubated with different concentrations of the Rac1 ...
(A) PBMCs were incubated with different concentrations of the Rac1 ...
A–F) Neutrophils ( , ) and PBMC (•, ) were incubated with ( , •) or ...
A–F) Neutrophils ( , ) and PBMC (•, ) were incubated with ( , •) or ...
A–F) Neutrophils ( , ) and PBMC (•, ) were incubated with ( , •) or ...
A–F) Neutrophils ( , ) and PBMC (•, ) were incubated with ( , •) or ...
PBMCs were incubated with additional NaCl, before, during, before, and ...
PBMCs were incubated with additional NaCl, before, during, before, and ...
PBMCs were incubated with different ligands for TLRs and GPR15 ...
PBMCs were incubated with different ligands for TLRs and GPR15 ...
PBMCs were incubated in the presence or absence of 25 mM additional ...
PBMCs were incubated in the presence or absence of 25 mM additional ...
PFCs from TBP and PBMCs from healthy donors were incubated for eight ...
PFCs from TBP and PBMCs from healthy donors were incubated for eight ...
a Viability of PBMCs after incubation with CDDO-Me (20 nM/50 nM ...
a Viability of PBMCs after incubation with CDDO-Me (20 nM/50 nM ...
A. Resting PBMCs (n = 5) were incubated in medium for up to 7 days ...
A. Resting PBMCs (n = 5) were incubated in medium for up to 7 days ...
B-cell depletion. Freshly isolated PBMCs were incubated for two days ...
B-cell depletion. Freshly isolated PBMCs were incubated for two days ...
Morphology of the cells. PBMCs were incubated for 24 h in presence of ...
Morphology of the cells. PBMCs were incubated for 24 h in presence of ...
Normal donor PBMCs were incubated in complete medium (A), in the ...
Normal donor PBMCs were incubated in complete medium (A), in the ...
At the indicated time points, PBMC were incubated with AT2-inactivated ...
At the indicated time points, PBMC were incubated with AT2-inactivated ...
A. Resting PBMCs (n = 5) were incubated in medium for up to 7 days ...
A. Resting PBMCs (n = 5) were incubated in medium for up to 7 days ...
Cell extract from the incubation of PBMCs for 6 h with 1,2-13 C 2 ...
Cell extract from the incubation of PBMCs for 6 h with 1,2-13 C 2 ...
PBMCs were isolated form individual participants and stimulated with ...
PBMCs were isolated form individual participants and stimulated with ...
Schematic overview of experimental workflow. PBMCs were either ...
Schematic overview of experimental workflow. PBMCs were either ...
PBMC cytokine responses. PBMC were incubated with stimuli for innate ...
PBMC cytokine responses. PBMC were incubated with stimuli for innate ...

Loading image details...

Source
Dimensions